Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · July 31, 2019

US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin

JAMA Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Dermatology
US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin
JAMA Dermatol 2019 Jul 17;[EPub Ahead of Print], E Tkachenko, S Singer, P Sharma, J Barbieri, A Mostaghimi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading